Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06977633

Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes

A pH-Responsive Hydrogel Microneedle Patch for Continuous Measurement of Ketone Bodies and Glucose: CGM-CKM

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Mahla Poudineh · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate a CGM-CKM device during insulin suspension in patients with type 1 diabetes. 10 patients with T1D will be recruited for a pilot study. The patients will visit CTRU at Stanford Medical School. The CGM-CKM device will be applied to the upper arm area of patients and baseline ketone and glucose measurement will be performed for one hour prior to suspending or disconnecting the pump. Upon baseline measurement, the pump will be disconnected for 3 hours while the electrochemical signals are collected from the CGM-CKM device. During the 3 hours of pump disconnection, blood samples will be collected every 5 minutes from participants for analyzing their insulin and glucagon using conventional ELISA kits and glucose and ketone using standard meters.

Detailed description

This is a non-significant risk (NSR) device study not conducted under an IDE, in accordance with 21 CFR 812.2(b)

Conditions

Interventions

TypeNameDescription
BEHAVIORALTemporary Insulin SuspensionParticipants will suspend insulin delivery from their personal insulin pumps for up to 3 hours. Insulin suspension is temporary and participant-driven under supervision.
DEVICEGlucose and ketone sensorThe participants wear a prototype continuous glucose-ketone monitoring (CGM-CKM) device using painless hydrogel microneedles for 4 hours.

Timeline

Start date
2025-08-30
Primary completion
2026-02-28
Completion
2027-04-30
First posted
2025-05-18
Last updated
2025-07-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06977633. Inclusion in this directory is not an endorsement.